Table 3.
Evolution of Endometrial Variables Pre and Post Treatment eMSCs
| Variables | PreSCs | Post SCs | p value |
|---|---|---|---|
| Endometrial Thickness | 5.25±1.24 | 9.93 ± 0.77 | 0.000* |
| Endometrial Flow Cytometry | |||
| Li/PC | |||
| Normal | 13/29 (44.8%) | 20/29 (69%) | 0.167† |
| Abnormal | 16/29 (55.2%) | 9/29 (31%) | |
| LT | |||
| Normal | 15/29 (51.7%) | 26/29 (89.7%) | 0.013† |
| Abnormal | 14/29 (48.3%) | 3/29 (10.3%) | |
| LB | |||
| Normal | 8/29 (27.6%) | 18/29 (62.1%) | 0.002† |
| Abnormal | 21/29 (72.4%) | 11/29 (37.9%) | |
| NK | |||
| Normal | 14/29 (48.3%) | 23/29 (79.3%) | 0.049† |
| Abnormal | 15/29 (51.7%) | 6/29 (20.7%) | |
| CD4 | |||
| Normal | 14/29 (48.3%) | 21/29 (72.4%) | 0.118† |
| Abnormal | 15/29 (51.7%) | 8/29 (27.6%) | |
| CD8 | |||
| Normal | 13/29 (44.8%) | 25/29 (86.2%) | 0.000† |
| Abnormal | 16/29 (55.2%) | 4/29 (13.8%) | |
| CD4/CD8 | |||
| Normal | 13/29 (44.8%) | 28/29 (96.6%) | 0.000† |
| Abnormal | 16/29 (55.2%) | 1/29 (3.4%) | |
| Endometrial Histopathology | |||
| Normal | 6/29 (20.7%) | 17/29 (58.6%) | 0.007† |
| Abnormal | 23/29 (79.3%) | 12/29 (41.4%) |
*
T-test paired samples,
†
McNemar Test.